Back to top

Gilead Sciences: A Strong Buy on Robust Sales and Promising Future Catalysts

Analyst Evan Seigerman of BMO Capital assigned a Buy rating on Gilead Sciences (GILD – Research Report), reducing the price target to $80.00. Evan ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Gilead Sciences, Inc. (GILD)

General Mills, Inc. (GIS)